Results: Altogether 9036 patients were treated with moxifloxacin, of whom 2405 adult men and women had sinusitis. Sinusitis symptoms were improved or cured in at least 92% of patients ...

On Monday, GSK plc (NYSE:GSK) released headline results from the phase 3 trials ANCHOR-1 and ANCHOR-2, which assessed the ...

In an ideal world, we wouldn’t need tools like GoodRx to streamline visits and reduce costs because health care would be ...

We are pleased to have fully enrolled the second of our two pivotal trials of LYR-210 in CRS patients, and our team is moving forward expeditiously to report the results in Q2 of next year,” said ...

Cooler weather has arrived in the Midlands. That means we will soon see an increase in respiratory illnesses, like flu and ...

Shingles is a common condition that lies dormant in a third of adults over their lifetime. A pharmacist has shared the key ...

sinus infection, bronchitis, or any symptom/illness. Future stewardship interventions to reduce inappropriate patient antibiotic expectations should (1) inform patients of the symptoms/illnesses ...

Adults get a cold an average of two to ... particularly if you are at risk for serious illness. Some symptoms of a sinus ...

A pharmacist is urging the public to be on alert for shingles, a common "dormant" condition that affects one in three adults ...

Question: My kids have colds. I am sure they will have many more as winter approaches. Do I need to keep them home from ...

GSK plc has announced positive results from its Phase III ANCHOR trials for depemokimab, a biologic treatment for chronic ...